LOLLO Giovanna

Spécialité :

Génie Pharmaceutique

Compétences :

Design and development of novel drug delivery nanosystems to overcome physiological barriers for the treatment of various diseases.

Bureau : G119

Téléphone : 04 72 44 85 84

EMail

24 documents

  • Giovanna Lollo, Gustavo Rivera-Rodriguez, Jérôme Bejaud, Tristan Montier, Catherine Passirani-Malleret, et al.. Polyglutamic acid–PEG nanocapsules as long circulating carriers for the delivery of docetaxel. European Journal of Pharmaceutics and Biopharmaceutics, Elsevier, 2014, 87 (1), Non spécifié. ⟨10.1016/j.ejpb.2014.02.004⟩. ⟨hal-03179499⟩
  • Giovanna Lollo, Marie Vincent, Gabriella Ullia, Laurent Lemaire, Dominique Couez, et al.. CpG-Paclitaxel-loaded LNC for the treatment of glioblastoma. 2nd International Meeting on Translational Nanomedicines, 2014, Angers, France. 2014. ⟨hal-03173120⟩
  • Giovanna Lollo, Gabriela Veroniva Ullio Gamboa, Marie Vincent, Edmundo Fuentes, Catherine Passirani-Malleret, et al.. Curcumin-loaded lipid nanocapsules: development, optimization and anticancer activity in vitro. 2nd International Meeting on Translational Nanomedicines, 2014, Angers, France. 2014. ⟨hal-03184074⟩
  • Gustavo Rivera-Rodriguez, Giovanna Lollo, Tristan Montier, Jean-Pierre Benoit, Catherine Passirani-Malleret, et al.. In vivo evaluation of poly-l-asparagine nanocapsules as carriers for anti-cancer drug delivery. International Journal of Pharmaceutics, Elsevier, 2013, 458 (1), pp.83-9. ⟨10.1016/j.ijpharm.2013.09.038⟩. ⟨hal-03178899⟩